The ABCs of Anticoagulation and Reversal : Do You Know Your Direct Oral Anticoagulants (DOACs) is organized by Boston University School of Medicine Continuing Medical Education and will be held during Jun 23, 2017 - Jun 22, 2018.
The target audience for this medical event is to inform cardiologists, specialists in internal medicine, hospitalists, surgeons, physician assistants, nurse practitioners, nurses and pharmacists who manage patients undergoing treatment with anticoagulant therapies.This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Conference Objectives are :
• Recognize which patients are candidates for reversal and the potential thromboembolic consequences of discontinuing and reversing anticoagulation.
• Discuss the evidence to reverse warfarin with Vitamin K, FFP and PCC.
• Examine the role and clinical utility of reversal agents for various DOACs.
• Explore other reversal agents that are currently in development.
Additional details will be posted as soon as they are available.
Hematology Blood and Marrow Transplant